Disease Modification in Pulmonary Arterial Hypertension

I’m Aware That I’m Rare: the phaware® podcast
Episode 527 - Roham Zamanian, MD, FCCP

Dr. Roham Zamanian, discusses the concept of “disease modification” in the treatment of pulmonary hypertension. He describes how this idea emerged from discussions with colleagues about the future of pulmonary hypertension therapies, and the potential for treatments to impact the underlying disease process beyond just reducing pulmonary artery pressures.